vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Gen Digital (GEN). Click either name above to swap in a different company.
Gen Digital is the larger business by last-quarter revenue ($1.2B vs $950.5M, roughly 1.3× Astrana Health, Inc.). Gen Digital runs the higher net margin — 15.5% vs 0.7%, a 14.8% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 28.5%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 13.2%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Gen Digital Inc. is a multinational software company co-headquartered in both Tempe, Arizona (USA) and Prague, Czech Republic (EU). The company provides cybersecurity software, financial technology, and services. Gen is a Fortune 500 company and a member of the S&P 500 stock-market index. It is listed at both NASDAQ and Prague Stock Exchange. Its portfolio includes Norton, Avast, LifeLock, Avira, AVG, ReputationDefender, MoneyLion and CCleaner.
ASTH vs GEN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.2B |
| Net Profit | $6.6M | $192.0M |
| Gross Margin | — | 78.4% |
| Operating Margin | 1.9% | 34.9% |
| Net Margin | 0.7% | 15.5% |
| Revenue YoY | 42.9% | 28.5% |
| Net Profit YoY | 184.4% | 6.1% |
| EPS (diluted) | $0.12 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.2B | ||
| Q4 25 | $950.5M | $1.2B | ||
| Q3 25 | $956.0M | $1.3B | ||
| Q2 25 | $654.8M | — | ||
| Q1 25 | $620.4M | $1.0B | ||
| Q4 24 | $665.2M | $986.0M | ||
| Q3 24 | $478.7M | $974.0M | ||
| Q2 24 | $486.3M | $965.0M |
| Q1 26 | — | $192.0M | ||
| Q4 25 | $6.6M | $134.0M | ||
| Q3 25 | $373.0K | $135.0M | ||
| Q2 25 | $9.4M | — | ||
| Q1 25 | $6.7M | $142.0M | ||
| Q4 24 | $-7.8M | $159.0M | ||
| Q3 24 | $16.1M | $161.0M | ||
| Q2 24 | $19.2M | $181.0M |
| Q1 26 | — | 78.4% | ||
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 78.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 80.3% | ||
| Q4 24 | — | 80.4% | ||
| Q3 24 | — | 80.1% | ||
| Q2 24 | — | 80.3% |
| Q1 26 | — | 34.9% | ||
| Q4 25 | 1.9% | 35.9% | ||
| Q3 25 | 2.0% | 35.5% | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.3% | 41.3% | ||
| Q4 24 | 0.1% | 37.9% | ||
| Q3 24 | 5.9% | 41.3% | ||
| Q2 24 | 6.2% | 43.2% |
| Q1 26 | — | 15.5% | ||
| Q4 25 | 0.7% | 11.0% | ||
| Q3 25 | 0.0% | 10.7% | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.1% | 14.1% | ||
| Q4 24 | -1.2% | 16.1% | ||
| Q3 24 | 3.4% | 16.5% | ||
| Q2 24 | 3.9% | 18.8% |
| Q1 26 | — | $0.31 | ||
| Q4 25 | $0.12 | $0.21 | ||
| Q3 25 | $0.01 | $0.22 | ||
| Q2 25 | $0.19 | — | ||
| Q1 25 | $0.14 | $0.22 | ||
| Q4 24 | $-0.14 | $0.26 | ||
| Q3 24 | $0.33 | $0.26 | ||
| Q2 24 | $0.40 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | — |
| Total DebtLower is stronger | — | $8.4B |
| Stockholders' EquityBook value | $779.3M | $2.3B |
| Total Assets | $2.2B | $15.8B |
| Debt / EquityLower = less leverage | — | 3.61× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | $1.0B | ||
| Q4 24 | $290.8M | $883.0M | ||
| Q3 24 | $350.3M | $737.0M | ||
| Q2 24 | $327.7M | $644.0M |
| Q1 26 | — | $8.4B | ||
| Q4 25 | — | $8.7B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $8.3B | ||
| Q4 24 | — | $8.5B | ||
| Q3 24 | — | $8.5B | ||
| Q2 24 | — | $8.5B |
| Q1 26 | — | $2.3B | ||
| Q4 25 | $779.3M | $2.5B | ||
| Q3 25 | $775.5M | $2.4B | ||
| Q2 25 | $765.5M | — | ||
| Q1 25 | $745.4M | $2.3B | ||
| Q4 24 | $712.7M | $2.2B | ||
| Q3 24 | $704.6M | $2.1B | ||
| Q2 24 | $678.9M | $2.0B |
| Q1 26 | — | $15.8B | ||
| Q4 25 | $2.2B | $16.1B | ||
| Q3 25 | $2.2B | $16.4B | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | $15.5B | ||
| Q4 24 | $1.4B | $15.4B | ||
| Q3 24 | $1.3B | $15.5B | ||
| Q2 24 | $1.3B | $15.4B |
| Q1 26 | — | 3.61× | ||
| Q4 25 | — | 3.54× | ||
| Q3 25 | — | 3.75× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.64× | ||
| Q4 24 | — | 3.94× | ||
| Q3 24 | — | 4.06× | ||
| Q2 24 | — | 4.33× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $541.0M | ||
| Q3 25 | $10.0M | $409.0M | ||
| Q2 25 | $90.9M | — | ||
| Q1 25 | $16.6M | $473.0M | ||
| Q4 24 | $-10.9M | $326.0M | ||
| Q3 24 | $34.0M | $158.0M | ||
| Q2 24 | $23.2M | $264.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $535.0M | ||
| Q3 25 | $7.4M | $405.0M | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | $470.0M | ||
| Q4 24 | $-13.5M | $318.0M | ||
| Q3 24 | $31.7M | $156.0M | ||
| Q2 24 | $20.4M | $262.0M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 43.9% | ||
| Q3 25 | 0.8% | 32.2% | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | 46.5% | ||
| Q4 24 | -2.0% | 32.3% | ||
| Q3 24 | 6.6% | 16.0% | ||
| Q2 24 | 4.2% | 27.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | 0.3% | ||
| Q4 24 | 0.4% | 0.8% | ||
| Q3 24 | 0.5% | 0.2% | ||
| Q2 24 | 0.6% | 0.2% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 4.04× | ||
| Q3 25 | 26.69× | 3.03× | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | 3.33× | ||
| Q4 24 | — | 2.05× | ||
| Q3 24 | 2.11× | 0.98× | ||
| Q2 24 | 1.21× | 1.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
GEN
| Cyber Safety Platform | $819.0M | 66% |
| Trust Based Solutions | $421.0M | 34% |
| Net Interest Income On Notes Receivable | $4.0M | 0% |
